Electrical Epidural Stimulation Test for Detecting Epidural Catheter Reactivation in Obstetric Population
Launched by STANFORD UNIVERSITY · Jul 20, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to determine if an epidural catheter, which is a thin tube used for pain relief during and after childbirth, can be safely reactivated for additional procedures like tubal ligation. After giving birth, many women keep their epidural catheters in place but turned off, and this study aims to see if an electrical test can help predict whether these catheters can be used again for pain management.
To participate, women need to be at least 18 years old and have had an epidural or combined spinal-epidural anesthesia during childbirth. They should also be planning to have a procedure that requires the use of this anesthesia for pain relief. However, certain conditions may prevent some women from joining, such as allergies to specific medications, having a neurological disorder, or previous surgeries that might complicate the use of an epidural. This study is not yet recruiting participants, but it represents an important step in improving pain management options for postpartum women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females, 18 years and older
- • American Society of Anesthesiologists physical status I or II
- • Status post natural labor/birth process or C-section
- • Has epidural or CSE catheter
- • Upcoming procedure requiring epidural/CSE anesthesia for pain management
- Exclusion Criteria:
- • Contraindication to regional anesthesia
- • Allergy or hypersensitivity to lidocaine, bupivacaine, or fentanyl
- • Use of sedatives or opioids
- • Abnormal vertebrae anatomy
- • Neurological disorder with lumbar involvement
- • Implanted electronic devices
- • Did not receive epidural or CSE anesthesia
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials